Support 100 years of independent journalism.

  1. World
  2. Australasia
24 August 2021updated 03 Sep 2021 1:43pm

Why are Australia and New Zealand so far behind on vaccination?

New Zealand and Australia only have enough doses to fully vaccinate 27 per cent and 33 per cent of their populations.   

By Ben van der Merwe

Once praised for their effective containment of Covid-19, the governments of Australia and New Zealand have attracted growing criticism for the slow pace of their vaccine programmes. Only in late July did the pace of vaccination in either country reach levels surpassed by the US and UK in January.

In New Zealand, prime minister Jacinda Ardern has extended a nationwide lockdown, while in Australia, Sydney is entering its ninth week in lockdown and Melbourne and Canberra are also locked down. 

A lack of vaccines is holding back New Zealand and Australia
Vaccine supply and distribution, latest data available

*Full courses (e.g. two doses of Pfizer, one of Johnson & Johnson) delivered by the manufacturer
Source: UNICEF/Our World in Data

In both countries, the chief cause is a lack of supply. According to Unicef, New Zealand and Australia have so far received enough doses to fully vaccinate just 27 per cent and 33 per cent of their populations, respectively.

That’s the lowest in the OECD, and significantly below the bloc’s average of 65 per cent. Mexico and Colombia are the only other OECD members to have received less than 40 per cent of the doses needed to inoculate their populations.

Sign up for The New Statesman’s newsletters Tick the boxes of the newsletters you would like to receive. Quick and essential guide to domestic and global politics from the New Statesman's politics team. The best of the New Statesman, delivered to your inbox every weekday morning. The New Statesman’s global affairs newsletter, every Monday and Friday. A handy, three-minute glance at the week ahead in companies, markets, regulation and investment, landing in your inbox every Monday morning. Our weekly culture newsletter – from books and art to pop culture and memes – sent every Friday. A weekly round-up of some of the best articles featured in the most recent issue of the New Statesman, sent each Saturday. A weekly dig into the New Statesman’s archive of over 100 years of stellar and influential journalism, sent each Wednesday. Sign up to receive information regarding NS events, subscription offers & product updates.
I consent to New Statesman Media Group collecting my details provided via this form in accordance with the Privacy Policy

New Zealand’s supply issues have been blamed on the government’s decision in March to cancel orders with all vaccine manufacturers other than Pfizer.

Ardern has attributed the supply shortages to Pfizer’s prioritisation of countries at greater risk. “People [in New Zealand and Australia] are literally not dying while they wait, so that means delivery has been different,” she told parliament in April.

Others have suggested that the delays may be due to the government only securing a supply agreement with Pfizer in October 2020, five months after similar deals were reached by the UK and US. The details of the agreements remain confidential.

Content from our partners
Executing business ideas is easier than ever, and it’s going to kill a lot of companies
The Interview: John Bennett on European markets
Why mayors will rule the world